Avanish Vellanki ’97 appointed president and CEO of Garuda Therapeutics
Vellanki studied biology at Carleton.
Avanish Vellanki ’97 has been appointed president and CEO of Garuda Therapeutics, a biotechnology company pioneering off-the-shelf, blood stem cell therapies.